A vaccine to protect people against the common sexually transmitted infection chlamydia has passed initial safety tests. It is the first of its kind to enter human trials. Experts say immunisation ...
The WHO estimates that 92 million and 62 million new cases of genital Chlamydia trachomatis and ... Rapid point-of-care diagnostic tests (RDTs) are particularly valuable as they allow immediate ...
Reviews also examined evidence for chlamydia prevalence, risk factors, accuracy of diagnostic tests and cost-effectiveness. Non-pregnant women at increased risk One randomized trial in women with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results